Pharma

Cute snail slowly climbing piles of coins
Pharma

BMS' Cobenfy underwhelms expectations in Q3 report

Cobenfy's modest uptake across schizophrenia creates concern around its potential Alzheimer's expansion.
Donavyn Coffey Oct 29, 2026 11:35am
Merck Co

For Merck, 2027 is ‘another year of investment’

Oct 29, 2026 11:23am
video
Why AIs Biggest Value in Pharma Is Confidence

Why AI’s Biggest Value in Pharma Is Confidence

Brought to you by /prompt
Lonza

Lonza upgrades plans for ADC expansion in Switzerland

Oct 29, 2026 10:12am
Podcast
Top Line Podcast - ZS

Clinical trials reach a new automation inflection point

Brought to you by IQVIA
direction arrow

Novartis refreshes myelofibrosis bid as Geron flops in ph. 3

Oct 29, 2026 8:15am